NEJM Evidence, a new digital journal within the New England Journal of Medicine group, help your research and training experience? Let the NIH Library know!Could access to
At the end of April, the NIH Library sent out the following message:
The NIH Library is pleased to offer trial access to NEJM Evidence through June 30, 2022. NEJM Evidence is a new clinical research journal that presents innovative research and ideas in clinical trial design and clinical decision-making. Each monthly issue includes original research, reviews, and case studies. Additional content includes perspectives from patients and trialists, short explanatory videos, and other article types to support learning and challenge thinking around how trials are designed, conducted, and analyzed.
NEJM Evidence helps readers understand how trials are assembled, run, and analyzed. This new journal brings a fresh approach modeled on the morning case-based rounds of medical training programs. NEJM Evidence also seeks to diversify its voices through the selection of its authors, reviewers, and editorial board.
Let Us Know What You Think
Explore NEJM Evidence and let us know what you think. During the trial access period (now through June 30), send feedback through the Library’s Suggest a Resource form—be sure to include the name of the resource (NEJM Evidence) in the “RECOMMENDED TITLE OR NAME OF PRODUCT” field.
NEJM Evidence is a publication of NEJM Group, which also publishes the New England Journal of Medicine (NEJM). For questions or more information, contact Lisa Scanlon at email@example.com.
The NIH Library
Download a PDF of this edition here:
- Letter from the Editor: June 2022
- Former Fellow Follow-Up with Dr. Parmit Singh, Research Scientist at the Dana-Farber Cancer Institute
- Former Fellow Follow-Up with Dr. Mayumi Miller, Research Biologist at the FDA
- Deconstructing Bias: Marginalization
- Clinical Corner: The NIH Library is Seeking Feedback on NEJM Evidence
- The Rep Report: June 2022
- June Announcements
- June Events